Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)

Publikation

Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)

Wissenschaftlicher Artikel/Review - 01.01.2007

Hess Dagmar, Ribi K, Ballabeni P, Schuller J C, Rauch D, Rochlitz C, Mattmann S, Schonenberger A, Pagani O, Thürlimann Beat, Köberle Dieter, Swiss Group for Clinical Cancer Research

Hess, Dagmar

Oberärztin mbF
Medizinische Onkologie und Hämatologie · Dept. I

Köberle, Dieter

Thürlimann, Beat

259

Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)

Hess, Dagmar

Köberle, Dieter

Thürlimann, Beat

Pagani, O

Schonenberger, A

Mattmann, S

Rochlitz, C

Rauch, D

Schuller, J C

Ballabeni, P

Ribi, K

Swiss Group for Clinical Cancer Research,